Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
22.38
-0.81 (-3.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,391,363
Open
23.19
Bid (Size)
22.39 (1)
Ask (Size)
22.88 (1)
Prev. Close
23.19
Today's Range
21.78 - 23.20
52wk Range
19.37 - 46.50
Shares Outstanding
88,140,978
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
June 28, 2024
Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.
Via
InvestorPlace
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
June 27, 2024
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.
Via
InvestorPlace
Performance
YTD
-27.38%
-27.38%
1 Month
+1.27%
+1.27%
3 Month
-17.78%
-17.78%
6 Month
-27.38%
-27.38%
1 Year
-45.12%
-45.12%
More News
Read More
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
June 26, 2024
Via
Benzinga
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Via
InvestorPlace
Unveiling 6 Analyst Insights On Intellia Therapeutics
June 24, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
June 04, 2024
Via
Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Via
Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Via
Benzinga
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024
June 21, 2024
Via
InvestorPlace
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
June 16, 2024
Via
Benzinga
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
June 10, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
June 09, 2024
Via
The Motley Fool
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
June 08, 2024
Via
The Motley Fool
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
June 06, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
June 06, 2024
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in June 2024
June 05, 2024
Via
InvestorPlace
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
June 04, 2024
Via
The Motley Fool
Why Intellia Therapeutics Shares Are Trading Higher Monday
June 03, 2024
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
May 30, 2024
Via
Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
May 28, 2024
Via
Benzinga
Topics
ETFs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 22, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 10, 2024
Via
The Motley Fool
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Just Say No to Drugs: 3 Pharma Stocks to Avoid
May 08, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.